ProShare Advisors’s Strata Critical Medical Inc SRTA Stock Holding History

ProShare Advisors’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,040	Closed	-$42K	–	1929
2026 Q1	$42K	Sell	10,040 -2,439	-20%	-$11.7K	﹤0.01%	1801
2025 Q4	$60K	Buy	12,479 +1,368	+12%	+$6.62K	﹤0.01%	1934
2025 Q3	$56.2K	Sell	11,111 -2,039	-16%	-$9.01K	﹤0.01%	1923
2025 Q2	$53K	Buy	13,150 +432	+3%	+$1.41K	﹤0.01%	1985
2025 Q1	$34.7K	Sell	12,718 -3,623	-22%	-$13K	﹤0.01%	1994
2024 Q4	$69.5K	Buy	16,341 +5,377	+49%	+$20.5K	﹤0.01%	2135
2024 Q3	$32.2K	Buy	+10,964	New	+$34.9K	﹤0.01%	2020
2024 Q2	–	Sell	-10,816	Closed	-$30.8K	–	1868
2024 Q1	$30.8K	Buy	+10,816	New	+$33.4K	﹤0.01%	1954

Other funds holding SRTA

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

NRCM

Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

PLC

Pillsbury Lake Capital San Francisco, California $366M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ProShare Advisors's SRTA Position: Q2 2026 in Review

ProShare Advisors sold out of Strata Critical Medical Inc (SRTA) in Q2 2026, closing a stake of 10,040 shares — an estimated $42K sold.

ProShare Advisors first reported a position in SRTA in Q1 2024 and held it in 8 quarters. The position peaked at $69.5K in Q4 2024. 140 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

ProShare Advisors reported no remaining Strata Critical Medical Inc position as of Q2 2026 after selling out during the quarter.
ProShare Advisors sold 10,040 Strata Critical Medical Inc shares in Q2 2026, an estimated $42K.
ProShare Advisors first reported a position in Strata Critical Medical Inc in Q1 2024 and held it in 8 quarters.
ProShare Advisors's Strata Critical Medical Inc position peaked at $69.5K in Q4 2024.
140 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.